Non-steroidal anti-inflammatory drugs (NSAIDs) have been implicated in causing negative cardiovascular outcomes, particularly in coronary artery disease (CAD) patients who have had a prior myocardial infarction (MI). In fact, as Schjerning Olsen and colleagues point out, current guidelines give the rather nebulous recommendation that duration of NSAID therapy should be as short as possible in CAD patients.
See the original article here:
Short- and long-term treatment with non-steroidal anti-inflammatory drugs increases risk of death or recurrent MI in those with previous MI
Related posts:
- Retinoids and Skin: Anti-Inflammatory and Pro-Happy Feet?
- Aubrey de Grey, SENS, anti-aging drugs, and clinical trials. – Slate Magazine
- Testing of viscous anti-HIV microbicides usingLactobacillus
- Synthesis of a novel class of steroidal tetrazolo[1,5-a]pyridinesviaintramolecular 1,3-dipolar cycloadditions
- American Diabetes Association Increases Focus on Prevention: Two New Reports Provide Further Support for Long-Term Cost and Medical Effectiveness of…
- Long-Term Results of Neurectomy in the Treatment of Morton’s Neuroma: More Than 10 Years’ Follow-up
- Bugs and Drugs 2011 (Slide Show)
- Use of an Anti-gravity Treadmill in the Rehabilitation of the Operated Achilles Tendon: A Pilot Study
- Expanding the Orphanage for Orphan Drugs
- Anticipation of a food ball increases short-term activity levels in growing pigs
